All In MedTech

FDA Clearance Tracker · P130022-S035

Nevro Corp Senza Spinal Cord Stimulation (SCS) System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 26, 2021 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Feb 26, 2021

Approved

Time to decision

198 days

Received Aug 12, 2020. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P130022-S035
Device name
Nevro Corp Senza Spinal Cord Stimulation (SCS) System
Applicant location
Redwood City, CA
Received
Aug 12, 2020
Decided
Feb 26, 2021
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P130022

Device type

Device class
Class III

Every decision under product code LGW

FDA's approval statement

As written in FDA's record.

Approval for a new Nordson Medical’s manufacturing site of the Implantable Pulse Generators (IPGs) of the Senza neuromodulation system located at 105 E Tasman Dr. San Jose, CA, 95134. Pro-Tech will continue to perform final packaging and sterilization.

Source documents

Other decisions for Nevro Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

2 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.